Pancreatic Cancer Research

Clinical trialPhase 1 / Phase 2Unknown

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)

Evaluation of the Safety and Efficacy of Esperanza Extract (Petiveria Alliacea) in Patients With Metastatic Gastrointestinal Tumors and Acute Leukemia

NCT05587088↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Outcome unknown
Phase
Phase 1 / Phase 2
Status
Unknown
Study type
Interventional
Start
15 December 2022
Expected end
15 June 2023
Enrollment
82 participants
Sites
1
Primary outcomes
Safety and efficacy
Sponsor
Other
Results posted
No
Last update
19 October 2022

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 25